Health Risks of Vaping
Vaping poses significant health risks including e-cigarette or vaping product use-associated lung injury (EVALI), cardiovascular damage, respiratory problems, and nicotine addiction, with particular dangers for adolescents, pregnant women, and those with pre-existing conditions. 1
Respiratory System Risks
EVALI (E-cigarette or Vaping Product Use-Associated Lung Injury):
- Caused over 2,800 hospitalizations and 68 deaths in 2019-2020 1
- Primarily linked to vitamin E acetate in THC-containing products 1
- Presents with respiratory symptoms (cough, shortness of breath), gastrointestinal symptoms, and constitutional symptoms 2
- Radiographically shows bilateral ground glass opacifications 3
Common respiratory effects:
Cardiovascular System Risks
- Nicotine in e-cigarettes causes:
Neurological Risks
- Neurotoxic effects of nicotine:
Chemical Exposure Risks
- Harmful chemicals in vaping aerosols:
- Propylene glycol and glycerin generate pulmonary irritants and carcinogenic compounds (formaldehyde, acetaldehyde, acrolein) when heated 3
- Metals from heating coils and cartridges (aluminum, chromium, iron, lead, nickel, etc.) 3
- Flavoring agents lack safety data for inhalation 3
- Volatile organic compounds (VOCs) and particulates 5
Vulnerable Populations at Higher Risk
Adolescents and youth:
Pregnant women:
Individuals with pre-existing conditions:
Environmental Risks
Secondhand exposure:
Thirdhand exposure:
Clinical Management of EVALI
For patients with suspected EVALI, the CDC recommends 2:
Initial clinical assessment:
- Vital signs, pulse oximetry
- Focused history and physical exam
- Rule out other possible etiologies (influenza, pneumonia)
Determine if hospitalization is needed based on:
- Oxygen saturation <95% on room air
- Respiratory distress
- Comorbidities that could compromise cardiopulmonary reserve
- Inability to discontinue e-cigarette use
For hospitalized patients:
- Discontinue all e-cigarette and vaping product use
- Consider corticosteroids (associated with clinical improvement)
- Ensure follow-up within 48 hours after discharge
- Schedule pulmonology follow-up within 2-4 weeks
Prevention and Recommendations
- Healthcare providers should routinely screen for all tobacco product use, including e-cigarettes 1
- Advise all patients, especially youth and non-smokers, to avoid initiating vaping 1
- For smoking cessation, recommend FDA-approved nicotine replacement therapy and counseling rather than e-cigarettes 1
- The American Heart Association, American Academy of Pediatrics, and American College of Cardiology recommend against using e-cigarettes for smoking cessation 1, 4
Important Caveats
- Long-term health effects remain incompletely understood due to the relatively recent emergence of these products 1, 6
- Rapidly evolving e-cigarette technology and formulations make standardized research challenging 1
- While e-cigarettes may have lower levels of some toxicants than combustible cigarettes, they are not harmless and introduce their own unique risks 5, 6
- Accidental poisonings in children from e-juice liquids have increased 5